THRIVENT FINANCIAL FOR LUTHERANS - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
THRIVENT FINANCIAL FOR LUTHERANS ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q2 2021$1,382,000
-7.4%
11,0090.0%0.00%0.0%
Q1 2021$1,493,000
-7.7%
11,009
-12.9%
0.00%
-25.0%
Q4 2020$1,618,000
+13.8%
12,6420.0%0.00%0.0%
Q3 2020$1,422,000
+18.0%
12,642
-0.1%
0.00%0.0%
Q2 2020$1,205,000
+6.0%
12,6510.0%0.00%0.0%
Q1 2020$1,137,000
-18.0%
12,651
-55.7%
0.00%
-20.0%
Q2 2018$1,386,000
+94.4%
28,578
+6.2%
0.01%
+66.7%
Q1 2017$713,000
+59.9%
26,920
+54.0%
0.00%
+50.0%
Q4 2016$446,000
-29.5%
17,4800.0%0.00%
-33.3%
Q3 2016$633,000
-65.5%
17,480
-53.5%
0.00%
-66.7%
Q4 2015$1,835,000
+142.4%
37,630
+23.7%
0.01%
+125.0%
Q3 2015$757,000
-35.8%
30,420
-18.4%
0.00%
-42.9%
Q2 2015$1,179,000
-16.9%
37,2700.0%0.01%
-12.5%
Q1 2015$1,418,000
-2.4%
37,270
-0.1%
0.01%0.0%
Q4 2014$1,453,000
+19.2%
37,300
-7.4%
0.01%
+14.3%
Q3 2014$1,219,00040,3000.01%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,449,300$59,537,000,0006.61%
Foresite Capital Management II, LLC 188,602$7,748,0004.36%
Foresite Capital Management III, LLC 254,923$10,472,0003.43%
Artal Group S.A. 1,500,000$61,620,0002.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,305,174$53,617,0001.93%
Asymmetry Capital Management, L.P. 82,473$3,388,0001.84%
QVT Financial LP 190,977$7,845,0001.66%
SECTORAL ASSET MANAGEMENT INC 269,396$11,067,0001.32%
Sofinnova Investments, Inc. 241,043$9,902,0000.91%
Novo Holdings A/S 119,708$4,918,0000.69%
View complete list of ACCELERON PHARMA INC shareholders